title: Reduction in Fas/APO-1 plasma concentrations correlates with improvement in left ventricular function in patients with idiopathic dilated cardiomyopathy treated with pentoxifylline.
authors.affiliation: Department of Cardiology Baragwanath Hospital University of the Witwatersrand Johannesburg, South Africa. dskudi@icon.co.za
authors.forename: D
authors.initials: D
authors.lastname: Skudicky
authors.forename: K
authors.initials: K
authors.lastname: Sliwa
authors.forename: A
authors.initials: A
authors.lastname: Bergemann
authors.forename: G
authors.initials: G
authors.lastname: Candy
authors.forename: P
authors.initials: P
authors.lastname: Sareli
mesh_terms: D000328:Adult; D017209:Apoptosis / Q000187:drug effects; D015415:Biomarkers / Q000097:blood; D002311:Cardiomyopathy, Dilated / Q000097:blood* / Q000188:drug therapy; D016022:Case-Control Studies; D004311:Double-Blind Method; D006801:Humans; D008875:Middle Aged; D010431:Pentoxifylline / Q000627:therapeutic use*; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use*; D011446:Prospective Studies; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis; D018487:Ventricular Dysfunction, Left / Q000097:blood*; D019014:fas Receptor / Q000097:blood*
chemical_list: D015415:Biomarkers; D010726:Phosphodiesterase Inhibitors; D014409:Tumor Necrosis Factor-alpha; D019014:fas Receptor; D010431:Pentoxifylline